These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 33459165)

  • 21. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipotoxicity dysregulates the immunoproteasome in podocytes and kidneys in type 2 diabetes.
    Lee HS; Suh JY; Kang BC; Lee E
    Am J Physiol Renal Physiol; 2021 Apr; 320(4):F548-F558. PubMed ID: 33586497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoA protects the podocytes against high glucose-induced apoptosis through YAP and plays critical role in diabetic nephropathy.
    Huang Z; Peng Y; Yu H; Yu X; Zhou J; Xiao J
    Biochem Biophys Res Commun; 2018 Oct; 504(4):949-956. PubMed ID: 30220545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
    Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
    J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
    Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
    Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emodin mitigates podocytes apoptosis induced by endoplasmic reticulum stress through the inhibition of the PERK pathway in diabetic nephropathy.
    Tian N; Gao Y; Wang X; Wu X; Zou D; Zhu Z; Han Z; Wang T; Shi Y
    Drug Des Devel Ther; 2018; 12():2195-2211. PubMed ID: 30034224
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impaired Podocyte Autophagy Exacerbates Proteinuria in Diabetic Nephropathy.
    Tagawa A; Yasuda M; Kume S; Yamahara K; Nakazawa J; Chin-Kanasaki M; Araki H; Araki S; Koya D; Asanuma K; Kim EH; Haneda M; Kajiwara N; Hayashi K; Ohashi H; Ugi S; Maegawa H; Uzu T
    Diabetes; 2016 Mar; 65(3):755-67. PubMed ID: 26384385
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Morroniside attenuates podocytes lipid deposition in diabetic nephropathy: A network pharmacology, molecular docking and experimental validation study.
    Chen Y; Chen M; Zhu W; Zhang Y; Liu P; Li P
    Int Immunopharmacol; 2024 Sep; 138():112560. PubMed ID: 38959541
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progranulin alleviates podocyte injury via regulating CAMKK/AMPK-mediated autophagy under diabetic conditions.
    Zhou D; Zhou M; Wang Z; Fu Y; Jia M; Wang X; Liu M; Zhang Y; Sun Y; Zhou Y; Lu Y; Tang W; Yi F
    J Mol Med (Berl); 2019 Nov; 97(11):1507-1520. PubMed ID: 31402399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AMPK signalling: Implications for podocyte biology in diabetic nephropathy.
    Szrejder M; Piwkowska A
    Biol Cell; 2019 May; 111(5):109-120. PubMed ID: 30702162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.
    Qi W; Keenan HA; Li Q; Ishikado A; Kannt A; Sadowski T; Yorek MA; Wu IH; Lockhart S; Coppey LJ; Pfenninger A; Liew CW; Qiang G; Burkart AM; Hastings S; Pober D; Cahill C; Niewczas MA; Israelsen WJ; Tinsley L; Stillman IE; Amenta PS; Feener EP; Vander Heiden MG; Stanton RC; King GL
    Nat Med; 2017 Jun; 23(6):753-762. PubMed ID: 28436957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nicotine worsens the severity of nephropathy in diabetic mice: implications for the progression of kidney disease in smokers.
    Hua P; Feng W; Ji S; Raij L; Jaimes EA
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F732-9. PubMed ID: 20685820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.
    Li J; Sun YBY; Chen W; Fan J; Li S; Qu X; Chen Q; Chen R; Zhu D; Zhang J; Wu Z; Chi H; Crawford S; Oorschot V; Puelles VG; Kerr PG; Ren Y; Nilsson SK; Christian M; Tang H; Chen W; Bertram JF; Nikolic-Paterson DJ; Yu X
    EMBO Rep; 2020 Feb; 21(2):e48781. PubMed ID: 31916354
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
    Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
    FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ATF4-dependent heme-oxygenase-1 attenuates diabetic nephropathy by inducing autophagy and inhibiting apoptosis in podocyte.
    Yuan S; Liang X; He W; Liang M; Jin J; He Q
    Ren Fail; 2021 Dec; 43(1):968-979. PubMed ID: 34157937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.
    Cheng H; Fan X; Moeckel GW; Harris RC
    J Am Soc Nephrol; 2011 Jul; 22(7):1240-51. PubMed ID: 21737546
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nrf-2 mediated heme oxygenase-1 activation contributes to the anti-inflammatory and renal protective effects of Ginkgo biloba extract in diabetic nephropathy.
    Chang TT; Chen YA; Li SY; Chen JW
    J Ethnopharmacol; 2021 Feb; 266():113474. PubMed ID: 33068650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Podocyte injury of diabetic nephropathy: Novel mechanism discovery and therapeutic prospects.
    Li X; Zhang Y; Xing X; Li M; Liu Y; Xu A; Zhang J
    Biomed Pharmacother; 2023 Dec; 168():115670. PubMed ID: 37837883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
    Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
    J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.